Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Patricia Boyle and Julie Schneider.
Connection Strength

8.657
  1. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.534
  2. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.223
  3. Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults. JAMA Neurol. 2023 01 01; 80(1):49-57.
    View in: PubMed
    Score: 0.219
  4. Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline. Stroke. 2022 01; 53(1):218-227.
    View in: PubMed
    Score: 0.201
  5. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.199
  6. The "cognitive clock": A novel indicator of brain health. Alzheimers Dement. 2021 12; 17(12):1923-1937.
    View in: PubMed
    Score: 0.196
  7. Association of Amyloid-? Pathology with Decision Making and Scam Susceptibility. J Alzheimers Dis. 2021; 83(2):879-887.
    View in: PubMed
    Score: 0.191
  8. Limbic-predominant Age-related TDP-43 Encephalopathy and Distinct Longitudinal Profiles of Domain-specific Literacy. Alzheimer Dis Assoc Disord. 2020 Oct-Dec; 34(4):299-305.
    View in: PubMed
    Score: 0.187
  9. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020 10 06; 95(14):e1951-e1962.
    View in: PubMed
    Score: 0.185
  10. Late-life cognitive decline is associated with hippocampal volume, above and beyond its associations with traditional neuropathologic indices. Alzheimers Dement. 2020 01; 16(1):209-218.
    View in: PubMed
    Score: 0.178
  11. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020 01 14; 94(2):e142-e152.
    View in: PubMed
    Score: 0.177
  12. Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019 12; 86(6):844-852.
    View in: PubMed
    Score: 0.176
  13. Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):315-320.
    View in: PubMed
    Score: 0.175
  14. Common age-related neuropathologies and yearly variability in cognition. Ann Clin Transl Neurol. 2019 11; 6(11):2140-2149.
    View in: PubMed
    Score: 0.175
  15. Reply: LATE to the PART-y. Brain. 2019 09 01; 142(9):e48.
    View in: PubMed
    Score: 0.174
  16. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 06 01; 142(6):1503-1527.
    View in: PubMed
    Score: 0.171
  17. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment: A Prospective Cohort Study. Ann Intern Med. 2019 05 21; 170(10):702-709.
    View in: PubMed
    Score: 0.169
  18. Risk Aversion and Alzheimer Disease in Old Age. Am J Geriatr Psychiatry. 2019 08; 27(8):851-861.
    View in: PubMed
    Score: 0.168
  19. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.167
  20. Cognitive decline after elective and nonelective hospitalizations in older adults. Neurology. 2019 02 12; 92(7):e690-e699.
    View in: PubMed
    Score: 0.166
  21. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019 01; 85(1):114-124.
    View in: PubMed
    Score: 0.166
  22. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018 10; 70:10-17.
    View in: PubMed
    Score: 0.159
  23. Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults. Neurobiol Aging. 2018 09; 69:177-184.
    View in: PubMed
    Score: 0.159
  24. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.159
  25. Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
    View in: PubMed
    Score: 0.158
  26. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.155
  27. Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018; 64(s1):S161-S189.
    View in: PubMed
    Score: 0.155
  28. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging. 2018 01; 61:138-145.
    View in: PubMed
    Score: 0.152
  29. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
    View in: PubMed
    Score: 0.146
  30. Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology. J Alzheimers Dis. 2017; 56(4):1485-1493.
    View in: PubMed
    Score: 0.145
  31. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016 11 01; 139(11):2983-2993.
    View in: PubMed
    Score: 0.143
  32. White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age. Ann Clin Transl Neurol. 2016 10; 3(10):791-800.
    View in: PubMed
    Score: 0.141
  33. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
    View in: PubMed
    Score: 0.139
  34. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
    View in: PubMed
    Score: 0.138
  35. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
    View in: PubMed
    Score: 0.132
  36. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.131
  37. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013 Nov; 70(11):1418-24.
    View in: PubMed
    Score: 0.116
  38. Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci. 2013; 5:50.
    View in: PubMed
    Score: 0.115
  39. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep; 74(3):478-89.
    View in: PubMed
    Score: 0.114
  40. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2013; 33 Suppl 1:S397-403.
    View in: PubMed
    Score: 0.110
  41. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.108
  42. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.108
  43. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012 May 02; 307(17):1798-800.
    View in: PubMed
    Score: 0.105
  44. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry. 2012 May; 69(5):499-505.
    View in: PubMed
    Score: 0.105
  45. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009; 18(3):691-701.
    View in: PubMed
    Score: 0.083
  46. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.075
  47. Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts. Ann Neurol. 2023 Nov 03.
    View in: PubMed
    Score: 0.058
  48. Primacy and recency effects in verbal memory are differentially associated with post-mortem frontal cortex p-tau 217 and 202 levels in a mixed sample of community-dwelling older adults. J Clin Exp Neuropsychol. 2023 Jul 13; 1-16.
    View in: PubMed
    Score: 0.057
  49. Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
    View in: PubMed
    Score: 0.054
  50. Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias. Neurology. 2022 03 08; 98(10):e1031-e1039.
    View in: PubMed
    Score: 0.051
  51. Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease. Biol Psychiatry. 2022 07 01; 92(1):25-33.
    View in: PubMed
    Score: 0.051
  52. Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias. Front Aging Neurosci. 2021; 13:765259.
    View in: PubMed
    Score: 0.050
  53. Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes. Alzheimers Dement (N Y). 2021; 7(1):e12201.
    View in: PubMed
    Score: 0.050
  54. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
    View in: PubMed
    Score: 0.047
  55. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.043
  56. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.043
  57. Education and cognitive reserve in old age. Neurology. 2019 03 05; 92(10):e1041-e1050.
    View in: PubMed
    Score: 0.042
  58. Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline. JAMA Neurol. 2017 12 01; 74(12):1473-1480.
    View in: PubMed
    Score: 0.039
  59. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res. 2017 03 30; 322(Pt B):233-240.
    View in: PubMed
    Score: 0.035
  60. Higher brain BDNF gene expression is associated with slower cognitive decline in older adults. Neurology. 2016 Feb 23; 86(8):735-41.
    View in: PubMed
    Score: 0.034
  61. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging. 2015 Oct; 36(10):2798-805.
    View in: PubMed
    Score: 0.033
  62. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.032
  63. Purpose in life and cerebral infarcts in community-dwelling older people. Stroke. 2015 Apr; 46(4):1071-6.
    View in: PubMed
    Score: 0.032
  64. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.031
  65. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci. 2014 Dec; 69(12):1536-44.
    View in: PubMed
    Score: 0.031
  66. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014 Aug 19; 83(8):702-9.
    View in: PubMed
    Score: 0.031
  67. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014 Jul; 35(7):1549-61.
    View in: PubMed
    Score: 0.030
  68. Harm avoidance and cerebral infarction. Neuropsychology. 2014 Mar; 28(2):305-11.
    View in: PubMed
    Score: 0.029
  69. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.029
  70. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.028
  71. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.028
  72. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology. 2013 Mar 26; 80(13):1202-8.
    View in: PubMed
    Score: 0.028
  73. Microvascular brain pathology and late-life motor impairment. Neurology. 2013 Feb 19; 80(8):712-8.
    View in: PubMed
    Score: 0.028
  74. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.027
  75. Emotional neglect in childhood and cerebral infarction in older age. Neurology. 2012 Oct 09; 79(15):1534-9.
    View in: PubMed
    Score: 0.027
  76. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012 Jul; 9(6):646-63.
    View in: PubMed
    Score: 0.026
  77. Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study. BMC Med. 2011 Apr 20; 9:42.
    View in: PubMed
    Score: 0.024
  78. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.024
  79. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009 Jul; 1170:730-5.
    View in: PubMed
    Score: 0.021
  80. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007 Jul; 64(7):802-8.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.